Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 9—September 2026

Dispatch

Serologic Evidence of Hantavirus Exposure in Humans, Italy, 2004–2018

Giulia Faolotto, Anishia WasbergComments to Author , Rommel Iheozor-Ejiofor, Essi M. Korhonen, Rosalba Minisini, Tarja Sironen, Ruut Joensuu, Jiaxin Ling, Åke Lundkvist, Olli Vapalahti, Eili Huhtamo, and Paolo Ravanini
Author affiliation: Maggiore della Carità University Hospital, Novara, Italy (G. Faolotto, P. Ravanini); Uppsala University, Uppsala, Sweden (A. Wasberg, J. Ling, Å. Lundkvis); University of Helsinki, Helsinki, Finland (R. Iheozor-Ejiofor, E.M. Korhonen, T. Sironen, R. Joensuu, O. Vapalahti, E. Huhtamo); University of Eastern Piedmont, Novara (R. Minisini); University of Helsinki and Helsinki University Hospital, HUSLAB, Helsinki (O. Vapalahti)

Main Article

Figure

Geographic distribution of study participants and seropositive cases by region in study of serologic evidence of hantavirus exposure in humans, Italy, 2004–2018

Figure. Geographic distribution of study participants and seropositive cases by region in study of serologic evidence of hantavirus exposure in humans, Italy, 2004–2018

Main Article

Page created: July 09, 2026
Page updated: July 09, 2026
Page reviewed: July 09, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external